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GFAP-containing tumor cells from examples of all three major types of human astrocytomas (i.e., well-differentiated, anaplastic, and glioblastoma multiforme). Astrocytoma cells in primary cultures prepared from all three astrocytomas also express this protein. It is not detectable in normal adult brain tissue. Immunoblot analyses using the IFAP-300kDa antibody confirm the presence of a 300-kDa polypeptide in fresh astrocytoma preparations enriched for IF proteins. These results suggest the utility of IFAP-300kDa as a marker for identification of human glioma cells both in vitro and in situ.
Little is known about the distinctive phenotypic characteristics of astrocytomas. Presently, the basis for identification and classification of human gliomas in a diagnostic setting rests primarily upon histologic and morphologic criteria (1) (2) (3) (4) (5) . The fundamental problem remains defining a means by which tumorous astrocytes can be distinguished from normal ones, both in situ and in vitro. The identification ofdistinctive phenotypic markers for astrocytomas should help to alleviate this situation. This approach furthermore would provide additional information about the basic cell biology of these tumors.
Proteins ofthe intermediate filament (IF) cytoskeleton that are developmentally regulated and show tissue type-specific expression hold great potential as cell markers for immunotyping human astrocytomas (6) . Indeed, glial fibrillary acidic protein (GFAP), an IF structural subunit protein specifically expressed in astrocytes, has been widely used as a marker for astrocytic tumors (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . Vimentin, another IF structural protein present in immature and some mature astrocytes, has also been shown to be expressed by astrocytomas (15, 17, 18) . However, these proteins are poor diagnostic markers because they are normal constituents of both mature and reactive astrocytes (19) (20) (21) .
In addition to such structural proteins, the IF cytoskeleton comprises IF-associated proteins (IFAPs) (22, 23 (26) .
Because markers of early differentiation can be reexpressed during tumorigenesis, we examined a spectrum of human brain astrocytoma types for IFAP-300kDa immunoreactivity. The specific expression of this IFAP by astrocytoma cells, both in situ and in vitro, is described. (24, 25) . As shown by immunoblot analysis, a polypeptide with a molecular weight of300 kDa is specifically identified (Fig. 1, lanes A, C, and E) . Immunoblot analysis of IF preparations obtained from astrocytoma specimens also identified the 300-kDa polypeptide (Fig. 1, lanes B and D) . In contrast, the 300-kDa protein was not identified in IF preparations isolated from normal brain tissue (Fig. 1, lane F) . The major polypeptides of the astrocytoma IF preparations comprised vimentin and GFAP structural IF proteins (Fig. 1,  lane B) .
MATERIALS AND METHODS
Methanol-fixed cryostat sections of fresh astrocytoma and normal brain specimens were examined by immunofluores- (Fig. 2) . As expected, all astrocytoma specimens (WDA, AA, and GBM) were immunopositive for both GFAP and vimentin. Interestingly, all were also immunopositive for IFAP-300kDa (Fig. 3) . This result was corroborated by double-label immunofluorescence microscopy, which demonstrated the presence of this IFAP in most of the GFAPpositive astrocytic tumor cells (Fig. 4) .
To determine the status of malignant astrocytes in vitro, primary cultures ofastrocytic tumor cells were prepared from WDA, AA, and GBM tumors, and the reactivities of IFAP300kDa and GFAP were again examined by immunofluorescence microscopy. Despite varied morphologies for the cultured astrocytoma cells, IFAP immunoreactivity was widely distributed throughout the cultures in 80% of the GFAPpositive cells, in agreement with the results for fresh tumors. Moreover, IFAP-300kDa was shown to colocalize with the GFAP-containing glial IFs (Fig. 5) , thereby supporting its IF cytoskeletal association as originally described (24, 25) .
DISCUSSION
In contrast to the other two major cytoskeletal elements (microtubules and microfilaments), IFs comprise a polydisperse family of at least 30 biochemically distinct subunit (structural) proteins that can be classified into six subgroups on the basis of amino acid sequence and structural domain organization (32) (33) (34) (35) . Because the expression of IF proteins is both tissue-type-specific and developmentaJly regulated (33, 36) , these proteins are widely used as markers to determine the origin of cells in studies of differentiation and in typifying tumors (6) . For example, within the macroglial cell lineage, the expression of IF structural proteins changes from vimentin in radial glia, to vimentin and GFAP in immature astrocytes, to GFAP in mature astrocytes (37) (38) (39) (40) (41) (42) (43) (44) .
The demonstration of both GFAP and vimentin in all astrocytoma specimens of the present study, in accord with previous reports (17, 18) , indicates that tissue-type-specific expression ofGFAP is maintained by these tumors. While the expression of vimentin suggests the relative differentiation state of these tumor cells (namely, immature), it is important to note that vimentin expression persists in many adult astrocytes, especially those of the white matter (19, 20 (24, 25) . IFAPs appear to play functional roles in the supramolecular organization of the cytoskeleton and in the regulation of IF interaction with other cellular components (22, 23 (45, 46) . In contrast, transient expression of a vimentin-associated 400-kDa IFAP (IFAPa-400) is described for chick radial glia-like cells derived from neuroectoderm (47) . Recently, we have described the differentiation-related expression of two vimentin-binding IFAPs, IFAP-300kDa and IFAP-70/280kDa, in rat radial glia and their direct derivatives (26, 28, 48) . Expression of the former IFAP in rat spinal cord ceases by postnatal day 2, while that of the latter continues until postnatal day 9 (26, 28) . These study are particularly significant: (i) IFAP-300kDa, a differentiation marker of developing astrocytes, is detectable in all astrocytic tumors but not in normal adult human astrocytes and (ii) IFAP-300kDa expression is maintained by cultured astrocytoma cells, permitting identification and selection of such cells for in vitro study ofthese tumors and their proteins. The expression of an early differentiation antigen by malignant cells is not totally unexpected given that certain properties of such cells suggest a less differentiated cellular state. Moreover, the IF cytoskeleton and the apparent regulators of its organization, like IFAP-300kDa (24, 25) , are intimately related to some ofthese properties, including cell size/shape, nuclear placement, and surface-membrane specialization for cell-cell adhesion (33, 49, 50) . However, the exact biological advantage conferred on astrocytoma cells by the reexpression of IFAP-300kDa is not known.
The identification of single glioma cells outside the central tumor region is not possible with anti-GFAP staining alone. However, IFAP-300kDa staining has identified some GFAPcontaining cells adjacent to the tumor mass (unpublished observations). Such cells may represent malignant astrocytes that otherwise cannot be identified and may be responsible for the high rate of tumor recurrence following resection of the original mass. Furthermore, IFAP-300kDa has not been detectable in reactive astrocytes induced by stab-wound and contusion injuries of the central nervous system of the rat (26) . Therefore, this IFAP may be clinically useful for assessing tumor cells that may reside in the surrounding gliotic and largely normal tissue. This feature is under current investigation.
